A phase II trial of oral idarubicin plus dibromodulcitol in advanced breast cancer-Reference-Cited by-同舟云学术

A phase II trial of oral idarubicin plus dibromodulcitol in advanced breast cancer

Published:1989-01 Issue:1 Volume:25 Page:141-143
ISSN:0277-5379
Container-title:European Journal of Cancer and Clinical Oncology
language:en
Short-container-title:European Journal of Cancer and Clinical Oncology

Author:

Smith David B.,Howell Anthony

Publisher

Elsevier BV

Subject

Oncology

Reference12 articles.

1. Relationship between effects on nucleic acid biosynthesis in cell cultures and toxicity of 4-demethoxy derivatives of daunorubicin and adriamycin;Suppino;Cancer Res,1977

2. Quantitative experimental evaluation of adriamycin cardiotoxicity in the mouse;Bertazzoli;Cancer Treat Rep,1979

3. Antitumour activity of 4-demethoxydaunorubicin administered orally;DiMarco;Cancer Treat Rep,1977

4. Phase II study of idarubicin given orally in the treatment of anthracycline-naive advanced breast cancer patients;Bastholt;Cancer Treat Rep,1987

5. Idarubicin in advanced breast cancer: a phase II study;Lionetto;Cancer Treat Rep,1986

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unanswered Questions in Malignant Bowel Obstruction;Journal of Palliative Care;2014-12

2. O;Hagers Handbuch der Pharmazeutischen Praxis;1999

3. Oral Idarubicin;Drugs & Aging;1997-07

4. Antiemetic Efficacy of Ondansetron and Metoclopramide, Both Combined with Corticosteroid, in Malignant Lymphoma Patients Receiving Non-Cisplatin Chemotherapy;Acta Oncologica;1996-01

5. Potential Role of Oral Anthracyclines in Older Patients with Cancer;Drugs & Aging;1994-05